SCHEMBL30068010

SCHEMBL30068010

COc1c(Cl)nc(CC(C)(C)O)nc1N1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MTOR P42345 6/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ KMT2A Q03164 2/20 0.37
▸ MAPT P10636 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ KCNQ3 O43525 1/20 0.36
▸ KCNQ2 O43526 1/20 0.36
▸ LMNA P02545 3/20 0.35
▸ HTT P42858 1/20 0.35
▸ TRPM8 Q7Z2W7 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ CHRM4 P08173 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26647274 1.00 MTOR (0.45) MTORSMN1; SMN2KMT2AMAPTL3MBTL1
SCHEMBL26770859 0.87 MTOR (0.43) MTORSMN1; SMN2KMT2AMAPTL3MBTL1
SCHEMBL26647453 0.83 MTOR (0.46) MTORSMN1; SMN2KMT2AMAPTL3MBTL1
SCHEMBL30692457 0.81 MTOR (0.43) MTORSMN1; SMN2KMT2AMAPTL3MBTL1
SCHEMBL26646952 0.80 MTOR (0.51) MTORSMN1; SMN2MAPTL3MBTL1KCNQ3
SCHEMBL30068156 0.78 MTOR (0.40) MTORSMN1; SMN2KMT2AMAPTL3MBTL1
SCHEMBL26646921 0.78 MTOR (0.40) MTORSMN1; SMN2KMT2AMAPTL3MBTL1
SCHEMBL12463160 0.78 SMN1; SMN2 (0.58) MTORSMN1; SMN2KMT2AMAPTL3MBTL1
SCHEMBL30828952 0.76 MTOR (0.48) MTORSMN1; SMN2KMT2AMAPTL3MBTL1
SCHEMBL26646985 0.76 MTOR (0.48) MTORSMN1; SMN2KMT2AMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337198-A1 POLO LIKE KINASE 4 INHIBITORS Oric Pharmaceuticals, Inc. (US) 2024-03-20 — — EP disclosed
WO-2022240876-A1 POLO LIKE KINASE 4 INHIBITORS ORIC PHARMACEUTICALS, INC. (US) 2022-11-17 — — WO disclosed
Send feedback